-
In Silico-Guided Rational Drug Design and Semi-synthesis of C(2)-Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitors
- Back
Metadata
Document Title
In Silico-Guided Rational Drug Design and Semi-synthesis of C(2)-Functionalized Huperzine A Derivatives as Acetylcholinesterase Inhibitors
Author
Anukanon S, Pongpamorn P, Tiyabhorn W, Chatwichien J, Niwetmarin W, Sessions RB, Ruchirawat S, Thasana N
Name from Authors Collection
Affiliations
Chulabhorn Graduate Institute; Chulabhorn Royal Academy; National Science & Technology Development Agency - Thailand; University of Bristol; Chulabhorn Research Institute
Type
Article
Source Title
ACS OMEGA
Year
2021
Volume
6
Issue
30
Page
19924-19939
Open Access
Green Published, gold
Publisher
AMER CHEMICAL SOC
DOI
10.1021/acsomega.1c02875
Format
Abstract
Huperzine A (1, Hup A), a lycodine-type Lycopodium alkaloid isolated from Thai clubmosses Huperzia squarrosa (G. Forst.) Trevis., H. carinata (Desv. ex. Poir.) Trevis., H. phlegmaria (L.), and Phlegmariurus nummulariifolius (Blume) Chambers (Lycopodiaceae), exerts inhibitory activity on acetylcholinesterase, a known target for Alzheimer's disease therapy. This study investigated the structure-activity relationship of C(2)-functionalized and O- or N-methyl-substituted huperzine A derivatives. In silico-guided screening was performed to search for potential active compounds. Molecular docking analysis suggested that substitution at the C(2) position of Hup A with small functional groups could enhance binding affinity with AChE. Consequently, 12 C(2)-functionalized and four O- or N-methyl-substituted compounds were semi-synthesized and evaluated for their eeAChE and eqBChE inhibitory activities. The result showed that 2-methoxyhuperzine A (10) displayed moderate to high eeAChE inhibitory potency (IC50 = 0.16 mu M) with the best selectivity over eqBChE (selectivity index = 3633). Notably, this work showed a case of which computational analysis could be utilized as a tool to rationally screen and design promising drug molecules, getting rid of impotent molecules before going more deeply on labor-intensive and time-consuming drug discovery and development processes.
Funding Sponsor
Center of Excellence on Environmental Health and Toxicology (EHT); Thailand Research Fund; Thailand Science Research and Innovation
License
CC-BY-NC-ND
Rights
Authors
Publication Source
WOS